R
Market Data
$41.75+$6.54 (+18.57%)
RAPP · Last trade
Prev Close
$35.21
Range (29d)
$35.21 – $42.05
Recent Filings
- 1445.3 KBRapport Therapeutics, Inc.Jun 29, 4:45 PM ET·0001958244-26-000411
- 8-K183.1 KBRapport Therapeutics, Inc.Jun 10, 4:12 PM ET·0001193125-26-265841
- 10-Q9.0 MBRapport Therapeutics, Inc.May 7, 7:30 AM ET·0001193125-26-210355
- 8-K474.4 KBRapport Therapeutics, Inc.May 7, 7:15 AM ET·0001193125-26-210324
- 10-K23.2 MBRapport Therapeutics, Inc.Mar 10, 7:25 AM ET·0001193125-26-099360
- 8-K537.8 KBRapport Therapeutics, Inc.Mar 10, 7:11 AM ET·0001193125-26-099336
- 8-K195.7 KBRapport Therapeutics, Inc.Jan 7, 8:35 AM ET·0001193125-26-005499
- 8-K25.6 MBRapport Therapeutics, Inc.Jan 7, 7:30 AM ET·0001193125-26-005446
- 10-Q10.3 MBRapport Therapeutics, Inc.Nov 6, 7:30 AM ET·0001193125-25-268096
- 8-K478.4 KBRapport Therapeutics, Inc.Nov 6, 7:15 AM ET·0001193125-25-268072
Insiders
10- ARCH Venture Fund XII, L.P.10% Owner
- Bredt DavidChief Scientific Officer
- Burow Kristina10% Owner
- Burrell Terry-AnnDirector
- CRANDELL KEITH10% Owner
- Ceesay AbrahamDirector, Chief Executive Officer
- GILLIS STEVEN10% Owner
- Galer Bradley S.Chief Medical Officer
- Gault CherylChief Operating Officer
- HEALY JAMESDirector
Tickers
Addresses
business
99 HIGH STREET SUITE 2100
BOSTON, MA, 02110
mailing
99 HIGH STREET SUITE 2100
BOSTON, MA, 02110
Former Names
- Rapport Therapeutics, Inc.2026-06-29